Press release
Head & Neck Cancer Drugs Market on target to reach $2,281 Million, with a CAGR of 7.3% by 2025
Latest report pusblished, titled, "Head & Neck Cancer Drugs Market by Drug Class (Chemotherapy, Immunotherapy, and Targeted Therapy) and Sales Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Stores): Global Opportunity Analysis and Industry Forecast, 2018 – 2025."
The report offers an extensive analysis of key market segments, top winning strategies, research methodology, evolving market trends, key segments, list of key players, market size & estimations, and competitive landscape. According to the report, the global head & neck cancer drugs market was estimated at $1.2 billion in 2017 and is expected to hit $2.2 billion in 2025, registering a CAGR of 7.3% from 2018-2025.
Download Sample of the Report @ https://www.alliedmarketresearch.com/request-sample/5174
Recent launch of advance drugs for treatment of head and neck cancer, increase in global geriatric population and rise in consumption of tobacco & alcohol has fueled the growth of global head & neck cancer drugs market. On the other hand, preferable use of radiation therapy over the drug therapy in initial stage has happened to restrain the growth to some extent. Simultaneously, Growth opportunities in emerging market with rise in purchasing power, increase in incidence of head & neck cancer and developing healthcare infrastructure and rise in number of pipeline drugs have made space for multiple opportunities in the sector.
Chemotherapy to maintain its leadership status by 2025
By drug class, chemotherapy contributed to nearly half of the total market and is expected to retain its headship status by 2025. Increase in adoption of chemotherapeutics along with radiation therapy for treatment of head & neck cancer has coaled the growth of the market. Also, rise in use of use of chemotherapeutics drugs in combination with other drugs has fueled the cause in more than one way.
Drug stores & retail pharmacies to rule the market during the estimated period
By sales channel, the drug stores & retail pharmacies segment contributed to nearly three-fifth of the total market and is anticipated to maintain its stand by 2023, airing a CAGR of 6.5%. Easy drug availability in the pharmacies has escalated the growth of the sector.
North America to dominate the market throughout the forecast period
The market of Head & Neck Cancer Drugs is evaluated across various regions including North America, Asia-Pacific, Europe, and Latin America, Middle East and Africa (LAMEA). North America accounted for nearly half of the total market share and is anticipated to maintain a CAGR of 6.3% from 2018-2025. Presence of major key players in the province, easy availability of exclusive drugs, high purchasing power, improved reimbursement policies and increase in prevalence of cancer have made the region hold the largest market share.
For More Info Visit @ https://www.alliedmarketresearch.com/purchase-enquiry/5174
Leading market players
Key market players evaluated in the research include Bristol-Myers Squibb Company, Eli Lilly and Company (ARMO Biosciences), F. Hoffmann-La Roche Ltd. (Genentech, Inc.), Merck KGaA (EMD Serono, Inc.), AstraZeneca PLC, Immutep Limited, Fortress Biotech, Inc. (Checkpoint Therapeutics, Inc.), Merck & Co., Inc., Novartis AG, and Pfizer Inc. The winning strategies they follow have helped them maintain their status in the market. Also, their unique outlook towards the market has been right behind their success story.
About us
Allied Market Research, a market research and advisory company of Allied Analytics LLP,
provides business insights and market research reports to large as well as small &
medium enterprises. The company assists its clients to strategize business policies and
achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection
to investment advice. The analysts at Allied Market Research dig out factors that help
clients to understand the significance and impact of market dynamics. The company
amplies client’s insight on the factors, such as strategies, future estimations, growth
or fall forecasting, opportunity analysis, and consumer surveys among others. As
follows, the company offers consistent business intelligent support to aid the clients
to turn into prominent business firm.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
The report offers an extensive analysis of key market segments, top winning strategies, research methodology, evolving market trends, key segments, list of key players, market size & estimations, and competitive landscape. According to the report, the global head & neck cancer drugs market was estimated at $1.2 billion in 2017 and is expected to hit $2.2 billion in 2025, registering a CAGR of 7.3% from 2018-2025.
Download Sample of the Report @ https://www.alliedmarketresearch.com/request-sample/5174
Recent launch of advance drugs for treatment of head and neck cancer, increase in global geriatric population and rise in consumption of tobacco & alcohol has fueled the growth of global head & neck cancer drugs market. On the other hand, preferable use of radiation therapy over the drug therapy in initial stage has happened to restrain the growth to some extent. Simultaneously, Growth opportunities in emerging market with rise in purchasing power, increase in incidence of head & neck cancer and developing healthcare infrastructure and rise in number of pipeline drugs have made space for multiple opportunities in the sector.
Chemotherapy to maintain its leadership status by 2025
By drug class, chemotherapy contributed to nearly half of the total market and is expected to retain its headship status by 2025. Increase in adoption of chemotherapeutics along with radiation therapy for treatment of head & neck cancer has coaled the growth of the market. Also, rise in use of use of chemotherapeutics drugs in combination with other drugs has fueled the cause in more than one way.
Drug stores & retail pharmacies to rule the market during the estimated period
By sales channel, the drug stores & retail pharmacies segment contributed to nearly three-fifth of the total market and is anticipated to maintain its stand by 2023, airing a CAGR of 6.5%. Easy drug availability in the pharmacies has escalated the growth of the sector.
North America to dominate the market throughout the forecast period
The market of Head & Neck Cancer Drugs is evaluated across various regions including North America, Asia-Pacific, Europe, and Latin America, Middle East and Africa (LAMEA). North America accounted for nearly half of the total market share and is anticipated to maintain a CAGR of 6.3% from 2018-2025. Presence of major key players in the province, easy availability of exclusive drugs, high purchasing power, improved reimbursement policies and increase in prevalence of cancer have made the region hold the largest market share.
For More Info Visit @ https://www.alliedmarketresearch.com/purchase-enquiry/5174
Leading market players
Key market players evaluated in the research include Bristol-Myers Squibb Company, Eli Lilly and Company (ARMO Biosciences), F. Hoffmann-La Roche Ltd. (Genentech, Inc.), Merck KGaA (EMD Serono, Inc.), AstraZeneca PLC, Immutep Limited, Fortress Biotech, Inc. (Checkpoint Therapeutics, Inc.), Merck & Co., Inc., Novartis AG, and Pfizer Inc. The winning strategies they follow have helped them maintain their status in the market. Also, their unique outlook towards the market has been right behind their success story.
About us
Allied Market Research, a market research and advisory company of Allied Analytics LLP,
provides business insights and market research reports to large as well as small &
medium enterprises. The company assists its clients to strategize business policies and
achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection
to investment advice. The analysts at Allied Market Research dig out factors that help
clients to understand the significance and impact of market dynamics. The company
amplies client’s insight on the factors, such as strategies, future estimations, growth
or fall forecasting, opportunity analysis, and consumer surveys among others. As
follows, the company offers consistent business intelligent support to aid the clients
to turn into prominent business firm.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
